ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Harald C. Eichstaedt
Igor Gregoric
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott-Burden, T.
Right arrow Articles by Frazier, O.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scott-Burden, T.
Right arrow Articles by Frazier, O.H.
Related Collections
Right arrow Mechanical Circulatory Assistance

Ann Thorac Surg 2002;73:1528-1533
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Use of autologous auricular chondrocytes for lining artificial surfaces: a feasibility study

Timothy Scott-Burden, PhDb,*, Jennifer P. Bosley, BSb, Doreen Rosenstrauch, RN, MDa,b, Kimberly D. Henderson, BSb, Fred J. Clubb, Jr, DVM, PhDc, Harald C. Eichstaedt, MDa, Kazuhiro Eya, MDa, Igor Gregoric, MDa, Timothy J. Myers, BSa, Branislav Radovancevic, MDa, O.H. Frazier, MD*a

a Cardiovascular Surgical Research Laboratories, Texas Heart Institute at St. Luke’s Episcopal Hospital, and The University of Texas Health Science Center at Houston, Houston, Texas, USA
b Vascular Cell Biology Laboratory, Texas Heart Institute at St. Luke’s Episcopal Hospital, and The University of Texas Health Science Center at Houston, Houston, Texas, USA
c Department of Cardiovascular Pathology, Texas Heart Institute at St. Luke’s Episcopal Hospital, and The University of Texas Health Science Center at Houston, Houston, Texas, USA

Accepted for publication December 3, 2001.

* Address reprint requests to Dr Frazier, 1101 Bates Ave, Suite P357, Houston, TX 77030 USA
e-mail: Doreen.Rosenstrauch{at}uth.tmc.edu

Background. Auricular elastic cartilage is a potential source of autologous cells for lining the luminal surfaces of cardiovascular prostheses. We tested this potential in vitro and in vivo using a left ventricular assist device (LVAD) and a calf model.

Methods. In vitro, auricular cartilage was harvested from the anesthetized ear of a calf, isolated, and cultured on tissue culture dishes. Primary chondrocytes were typed by immunocytochemistry, transferred into culture media, passaged twice, and seeded onto the blood-contacting luminal surfaces of four LVADs (HeartMate; Thoratec Corporation, Woburn, MA). Seeded cell linings were preconditioned under simulated flow conditions to promote cell adhesion to luminal surfaces. Seeding efficiency and cumulative cell loss under flow conditions were quantitated. In vivo, one of the four autologous chondrocyte-lined and preconditioned LVADs was implanted into the tissue-donor calf; run for 7 days; explanted; and evaluated grossly, by scanning electron microscopy, and by transmission electron microscopy.

Results. The efficiency of seeding chondrocytes onto the luminal surfaces of the four LVADs was 95.11% ± 4.23% (n = 4). Cumulative cell loss during preconditioning under flow conditions in vitro did not exceed 12% (n = 4). After 7 days of in vivo implantation, the luminal surfaces of the implanted LVAD demonstrated an intact, strongly adherent cellular lining.

Conclusions. Auricular elastic cartilage is a ready and easily accessible source of chondrocytes whose ability to produce collagen II and other important extracellular matrix constituents allows them to adhere strongly to the luminal surfaces of LVADs. The simple method of isolating and expanding auricular chondrocytes presented here could be used to provide strongly adherent autologous cell linings for LVADs and other cardiovascular devices. If and when chondrocytes can be genetically engineered to produce antithrombogenic factors and then used to line the luminal surfaces of LVADs or other cardiovascular prostheses, they may be able to improve the hemocompatibility of the blood–biomaterial interface in such devices. Our successful feasibility study in a calf model warrants further studies of this concept in vivo.




This article has been cited by other articles:


Home page
In VivoHome page
C. NABZDYK, L. PRADHAN, J. MOLINA, E. PERIN, D. PANIAGUA, and D. ROSENSTRAUCH
Auricular Chondrocytes - From Benchwork to Clinical Applications
In Vivo, May 1, 2009; 23(3): 369 - 380.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.